Overall, our results suggest that TIE-1 increases NER and DNA repair by up-regulating transcription of XPC, thereby rendering ovarian cancer cells resistant to DNA-adduct-type chemotherapeutic reagents. This evidence concerns the gene TIE1 and ovarian carcinoma.